Why the study?
Does heparin use or symptom duration affect the sensitivity of D-dimer for diagnosing acute pulmonary embolism?
Does heparin use or symptom duration affect the sensitivity of D-dimer for diagnosing acute pulmonary embolism?
Answers are grounded in this paper and cite their sources.
This letter highlights the potential confounding effect of symptom duration and heparin therapy on the diagnostic sensitivity of D-dimer for acute pulmonary embolism.
To the Editor. —Dr Goldhaber and colleagues1report a 93.3% sensitivity and 91.4% negative predictive value for a fibrin D-dimer value less than 500 ng/mL (Asserachrom D-Di enzyme immunoassay kit, Diagnostica Stago, Asniéres-sur-Seine, France) for acute pulmonary embolism using pulmonary angiography as the diagnostic reference standard. The authors report "no significant relationship between heparin use and D-dimer levels (P=.78)," but do not report the duration of heparin therapy or duration of symptoms prior to D-dimer measurement. Using the same assay, Bounameaux et al2found D-dimer levels to be significantly lower on days 3 and 7 compared with the day of presentation (day 1). Speiser et al3reported that elevated levels of D-dimer decrease within 24 hours in patients with acute deep vein thrombosis who are treated with heparin. Therefore, the D-dimer sensitivity for acute pulmonary embolism may be appreciably reduced in patients who have been symptomatic
No takes yet. Share an insight, caveat, or question.
John A. Heit (1994) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: